SEROMYCIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Seromycin, and when can generic versions of Seromycin launch?
Seromycin is a drug marketed by Sanaluz and is included in one NDA.
The generic ingredient in SEROMYCIN is cycloserine. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cycloserine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SEROMYCIN?
- What are the global sales for SEROMYCIN?
- What is Average Wholesale Price for SEROMYCIN?
Summary for SEROMYCIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 130 |
| Clinical Trials: | 31 |
| Patent Applications: | 3,759 |
| DailyMed Link: | SEROMYCIN at DailyMed |
Recent Clinical Trials for SEROMYCIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Calgary | Phase 2 |
| Shirley Ryan AbilityLab | Phase 4 |
| The Craig H. Neilsen Foundation | Phase 4 |
US Patents and Regulatory Information for SEROMYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanaluz | SEROMYCIN | cycloserine | CAPSULE;ORAL | 060593-001 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
